Nobel Prize Winner Helps Fight Cardiovascular Disease
One person dies every 30 seconds from heart disease. That's over 2,600 people every single day!! Cardiovascular disease refers to any disorder in any of the various parts of your cardiovascular system, which includes your heart and blood vessels. The heart is the human body's hardest working organ. Throughout life it continuously pumps blood enriched with oxygen and vital nutrients through a network of arteries to all parts of the body's tissues.
In order to perform the arduous task of pumping blood to the rest of the body, the heart muscle itself needs a plentiful supply of oxygen-rich blood, which is provided through a network of coronary arteries. These arteries carry oxygen-rich blood to the heart's muscular walls (the myocardium).
If blood flow to the myocardium is interrupted, an injury known as an infarct occurs, or in other words, a myocardial infarction, more commonly known as a heart attack. Cardiovascular diseases includes the following: arteriosclerosis, angina, high blood pressure, high cholesterol, heart attack, stroke, aneurysms, and arrhythmia.
New information has emerged that can help you decrease your risks of heart and arterial function disease. These findings are outlined in a November Scientific Statement published by the American Heart Association.
Discover the key compound nutrients that can decrease your risks of cardiovascular disease and can help you
- lower your blood pressure
- reduce LDL and total cholesterol levels
- support circulation and healthy blood vessels
- improve total heart health
Dr. Louis Ignarro, a Nobel Laureate in Medicine, received the Basic Research Prize of the American Heart Association for outstanding contributions to the advancement of cardiovascular science. Be one of the first to see what he helped to develop and exclusively endorse to combat the ever growing epidemic of heart disease!
Other helpful information regarding this article can be found at: http://www.givemerelief.com/cardiovascular_disease
For More Information Contact:
Direct line: (317)392-8764
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nobel Prize Winner Helps Fight Cardiovascular Disease here
News-ID: 841 • Views: 1964
More Releases from Givemerelief.com
Cardiovascular Disease Prevention
Reduce Your Risk of Cardiovascular Disease… Useful information about how you can lower your blood pressure, lower cholesterol, and decrease your risk of heart disease. One person dies every 30 seconds from heart disease. That's over 2,600 people every single day!! Cardiovascular disease refers to any disorder in any of the various parts of your cardiovascular system, which includes your heart and blood vessels. The heart is the
Increase Energy, Burn Fat, Lose Weight
Low Energy Levels Do you need that extra dose of caffeine to keep you going or keep you awake? Do you have trouble focusing or staying motivated? Do you need more energy? Your lack of proper nutrition is most likely the result. Shelbyville, IN - 12/07/05 - Improve Low Energy levels Fatigue, impaired concentration, short-term memory loss, muscle and joint pain, and sleep disturbances are common symptoms in today's
More Releases for Cardiovascular
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market Detailed Description by 2021
Cardiovascular diseases, also known as heart diseases, are diseases of heart and circulatory system. Some of the most common cardiovascular diseases are hypertensive heart disease, rheumatic heart disease, cerebrovascular heart disease, ischemic heart disease and inflammatory heart disease. Hypertensive heart disease occurs due to high blood pressure. Major problems associated with hypertensive heart disease include heart failure, hypertrophy, coronary heart disease and angina. Rheumatic heart disease is caused by rheumatic
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Market Overview of Cardiovascular Disease Industry 2018
Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" globally. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1313843 The most crucial risk
Medpace Implements Digisonics Solution for Cardiovascular Research
Medpace, a clinical research lab in Cincinnati, has implemented the Digisonics CVIS system for their latest cardiovascular research study. Digisonics provides Medpace’s researchers with unparalleled capabilities for image review and quantitation with over 1,100 preset measurements and an unlimited number of user defined fields as well as the ability to quickly document their findings in a comprehensive report. An additional remote reading application, DigiNet Pro, provides Medpace’s multiple users
Cardiovascular Stents Market — Trends, 2017–2025
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,